Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$268.64-0.48 (-0.18%)
Delayed quote: Sep 9, 2026, 10:35 AM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 10:35 AM EDT
The latest quarterly retained earnings is $171.66 Billion with a quarter-over-quarter change of +1.48%. Retained earnings represent the cumulative net income that has been kept by the company rather than distributed to shareholders as dividends. It's a key component of shareholders' equity.
Reported quarterly retained earnings; no daily interpolation.
$171.66B
$171.66 Billion
+1.48%
vs. $169.16B prior quarter
96
Quarters of data available
| Period | Retained Earnings | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $171.66B | +$2.50B | +1.48% |
| Quarter ended Mar 2026 | $169.16B | +$183.00M | +0.11% |
| Quarter ended Dec 2025 | $168.98B | +$1.70B | +1.01% |
| Quarter ended Sep 2025 | $167.28B | +$1.91B | +1.15% |
| Quarter ended Jun 2025 | $165.37B | +$2.74B | +1.68% |
| Quarter ended Mar 2025 | $162.63B | +$6.84B | +4.39% |
| Quarter ended Dec 2024 | $155.79B | +$612.00M | +0.39% |
| Quarter ended Sep 2024 | $155.18B | −$181.00M | -0.12% |
| Quarter ended Jun 2024 | $155.36B | +$1.98B | +1.29% |
| Quarter ended Mar 2024 | $153.38B | −$465.00M | -0.30% |
| Quarter ended Dec 2023 | $153.84B | +$1.31B | +0.86% |
| Quarter ended Oct 2023 | $152.54B | +$23.16B | +17.90% |
| Quarter ended Jul 2023 | $129.38B | +$4.82B | +3.87% |
| Quarter ended Apr 2023 | $124.56B | −$3.79B | -2.95% |
| Quarter ended Dec 2022 | $128.34B | +$428.00M | +0.33% |
| Quarter ended Oct 2022 | $127.92B | +$1.70B | +1.35% |
| Quarter ended Jul 2022 | $126.22B | +$1.84B | +1.48% |
| Quarter ended Apr 2022 | $124.38B | +$1.32B | +1.07% |
| Quarter ended Dec 2021 | $123.06B | +$1.97B | +1.63% |
| Quarter ended Oct 2021 | $121.09B | +$938.00M | +0.78% |
| Quarter ended Jul 2021 | $120.15B | +$3.65B | +3.13% |
| Quarter ended Apr 2021 | $116.51B | +$2.62B | +2.30% |
| Quarter ended Dec 2020 | $113.89B | −$941.00M | -0.82% |
| Quarter ended Sep 2020 | $114.83B | +$933.00M | +0.82% |
| Quarter ended Jun 2020 | $113.90B | +$997.00M | +0.88% |
| Quarter ended Mar 2020 | $112.90B | +$2.24B | +2.03% |
| Quarter ended Dec 2019 | $110.66B | +$1.42B | +1.30% |
| Quarter ended Sep 2019 | $109.24B | −$567.00M | -0.52% |
| Quarter ended Jun 2019 | $109.81B | +$3.16B | +2.96% |
| Quarter ended Mar 2019 | $106.65B | +$434.00M | +0.41% |
| Quarter ended Dec 2018 | $106.22B | −$1.40B | -1.30% |
| Quarter ended Sep 2018 | $107.62B | +$1.49B | +1.41% |
| Quarter ended Jul 2018 | $106.12B | +$1.78B | +1.71% |
| Quarter ended Apr 2018 | $104.34B | +$2.55B | +2.50% |
| Quarter ended Dec 2017 | $101.79B | −$13.01B | -11.33% |
| Quarter ended Oct 2017 | $114.81B | +$1.60B | +1.41% |
| Quarter ended Jul 2017 | $113.21B | +$1.56B | +1.40% |
| Quarter ended Apr 2017 | $111.64B | +$1.09B | +0.99% |
| Quarter ended Dec 2016 | $110.55B | +$1.69B | +1.55% |
| Quarter ended Oct 2016 | $108.86B | +$2.12B | +1.99% |
| Quarter ended Jul 2016 | $106.74B | +$1.75B | +1.66% |
| Quarter ended Apr 2016 | $104.99B | +$1.11B | +1.07% |
| Quarter ended Dec 2015 | $103.88B | +$1.13B | +1.10% |
| Quarter ended Sep 2015 | $102.75B | +$1.40B | +1.38% |
| Quarter ended Jun 2015 | $101.35B | +$2.70B | +2.73% |
| Quarter ended Mar 2015 | $98.66B | +$1.41B | +1.45% |
| Quarter ended Dec 2014 | $97.25B | +$685.00M | +0.71% |
| Quarter ended Sep 2014 | $96.56B | +$2.81B | +3.00% |
| Quarter ended Jun 2014 | $93.75B | +$2.36B | +2.58% |
| Quarter ended Mar 2014 | $91.39B | +$1.89B | +2.12% |
| Quarter ended Dec 2013 | $89.49B | +$1.79B | +2.04% |
| Quarter ended Sep 2013 | $87.70B | −$1.75B | -1.95% |
| Quarter ended Jun 2013 | $89.45B | +$2.21B | +2.53% |
| Quarter ended Mar 2013 | $87.24B | +$1.25B | +1.45% |
| Quarter ended Dec 2012 | $85.99B | +$1.11B | +1.31% |
| Quarter ended Sep 2012 | $84.88B | +$1.35B | +1.62% |
| Quarter ended Jul 2012 | $83.53B | +$427.00M | +0.51% |
| Quarter ended Apr 2012 | $83.10B | +$1.85B | +2.28% |
| Quarter ended Dec 2011 | $81.25B | −$1.38B | -1.67% |
| Quarter ended Oct 2011 | $82.63B | +$1.80B | +2.22% |
| Quarter ended Jul 2011 | $80.84B | +$1.32B | +1.66% |
| Quarter ended Apr 2011 | $79.52B | +$1.74B | +2.24% |
| Quarter ended Dec 2010 | $77.77B | +$501.00M | +0.65% |
| Quarter ended Oct 2010 | $77.27B | +$2.02B | +2.68% |
| Quarter ended Jul 2010 | $75.25B | +$2.07B | +2.83% |
| Quarter ended Apr 2010 | $73.18B | +$2.88B | +4.09% |
| Quarter ended Dec 2009 | $70.31B | +$835.00M | +1.20% |
| Quarter ended Sep 2009 | $69.47B | +$2.06B | +3.06% |
| Quarter ended Jun 2009 | $67.41B | +$2.01B | +3.07% |
| Quarter ended Mar 2009 | $65.40B | +$2.02B | +3.19% |
| Quarter ended Dec 2008 | $63.38B | +$1.50B | +2.43% |
| Quarter ended Sep 2008 | $61.88B | +$1.92B | +3.20% |
| Quarter ended Jun 2008 | $59.96B | +$2.15B | +3.72% |
| Quarter ended Mar 2008 | $57.81B | +$2.53B | +4.58% |
| Quarter ended Dec 2007 | $55.28B | +$1.08B | +2.00% |
| Quarter ended Sep 2007 | $54.20B | +$1.38B | +2.61% |
| Quarter ended Jul 2007 | $52.82B | +$1.97B | +3.87% |
| Quarter ended Apr 2007 | $50.85B | +$1.56B | +3.16% |
| Quarter ended Dec 2006 | $49.29B | +$1.08B | +2.24% |
| Quarter ended Oct 2006 | $48.21B | +$1.68B | +3.61% |
| Quarter ended Jul 2006 | $46.53B | +$1.82B | +4.06% |
| Quarter ended Apr 2006 | $44.71B | +$2.40B | +5.68% |
| Quarter ended Dec 2005 | $42.31B | +$1.89B | +4.67% |
| Quarter ended Oct 2005 | $40.42B | +$1.57B | +4.04% |
| Quarter ended Jul 2005 | $38.85B | +$1.55B | +4.16% |
| Quarter ended Apr 2005 | $37.30B | +$2.08B | +5.90% |
| Quarter ended Dec 2004 | $35.22B | +$201.00M | +0.57% |
| Quarter ended Sep 2004 | $35.02B | +$1.40B | +4.15% |
| Quarter ended Jun 2004 | $33.63B | +$1.47B | +4.58% |
| Quarter ended Mar 2004 | $32.15B | +$1.65B | +5.41% |
| Quarter ended Dec 2003 | $30.50B | +$1.00B | +3.40% |
| Quarter ended Sep 2003 | $29.50B | +$1.30B | +4.61% |
| Quarter ended Jun 2003 | $28.20B | +$348.00M | +1.25% |
| Quarter ended Mar 2003 | $27.85B | +$1.28B | +4.82% |
| Quarter ended Dec 2002 | $26.57B | +$767.00M | +2.97% |
| Quarter ended Sep 2002 | $25.80B | N/A | N/A |